cPLA2 is responsible for the process of asthma through producing arachidonic acid, which is subsequently metabolized into inflammatory mediators such as prostaglandins, thromboxanes, and leukotrienes, resulting in airway eosinophilia and bronchoconstriction [32]. The gene discussed is PLA2G4A; the disease is Increased total eosinophil count.